nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—nicotine dependence—alcohol dependence	0.782	1	CtDrD
Varenicline—CHRNA4—autonomic nervous system—alcohol dependence	0.00316	0.0789	CbGeAlD
Varenicline—CHRNA6—brainstem—alcohol dependence	0.00212	0.0531	CbGeAlD
Varenicline—CHRNA6—forebrain—alcohol dependence	0.00205	0.0512	CbGeAlD
Varenicline—CHRNA6—Nicotine Activity on Dopaminergic Neurons—DRD4—alcohol dependence	0.00189	0.0395	CbGpPWpGaD
Varenicline—CHRNA4—nerve—alcohol dependence	0.00178	0.0444	CbGeAlD
Varenicline—CHRNA6—Nicotine Activity on Dopaminergic Neurons—DRD2—alcohol dependence	0.00176	0.0368	CbGpPWpGaD
Varenicline—CHRNB2—Nicotine Activity on Dopaminergic Neurons—DRD4—alcohol dependence	0.00166	0.0348	CbGpPWpGaD
Varenicline—CHRNB2—Nicotine Activity on Dopaminergic Neurons—DRD2—alcohol dependence	0.00155	0.0324	CbGpPWpGaD
Varenicline—CHRNA6—midbrain—alcohol dependence	0.00135	0.0338	CbGeAlD
Varenicline—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD4—alcohol dependence	0.0012	0.0251	CbGpPWpGaD
Varenicline—CHRNB2—forebrain—alcohol dependence	0.00118	0.0294	CbGeAlD
Varenicline—CHRNA3—forebrain—alcohol dependence	0.00114	0.0285	CbGeAlD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ6—alcohol dependence	0.00113	0.0236	CbGpPWpGaD
Varenicline—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD2—alcohol dependence	0.00112	0.0233	CbGpPWpGaD
Varenicline—CHRNA6—nervous system—alcohol dependence	0.00111	0.0278	CbGeAlD
Varenicline—CHRNB2—adrenal cortex—alcohol dependence	0.00109	0.0273	CbGeAlD
Varenicline—CHRNA6—central nervous system—alcohol dependence	0.00107	0.0268	CbGeAlD
Varenicline—CHRNA6—cerebellum—alcohol dependence	0.00105	0.0262	CbGeAlD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ6—alcohol dependence	0.000993	0.0208	CbGpPWpGaD
Varenicline—CHRNA4—Nicotine Activity on Dopaminergic Neurons—DRD4—alcohol dependence	0.000926	0.0194	CbGpPWpGaD
Varenicline—CHRFAM7A—forebrain—alcohol dependence	0.000924	0.0231	CbGeAlD
Varenicline—CHRNA4—Nicotine Activity on Dopaminergic Neurons—DRD2—alcohol dependence	0.000863	0.0181	CbGpPWpGaD
Varenicline—CHRNA6—brain—alcohol dependence	0.000851	0.0213	CbGeAlD
Varenicline—CHRNA6—Transmission across Chemical Synapses—KCNJ6—alcohol dependence	0.000848	0.0177	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRB1—alcohol dependence	0.000816	0.0171	CbGpPWpGaD
Varenicline—CHRNB2—blood—alcohol dependence	0.000788	0.0197	CbGeAlD
Varenicline—CHRNB2—midbrain—alcohol dependence	0.000778	0.0194	CbGeAlD
Varenicline—CHRNA4—brainstem—alcohol dependence	0.000763	0.0191	CbGeAlD
Varenicline—CHRNB2—Transmission across Chemical Synapses—KCNJ6—alcohol dependence	0.000747	0.0156	CbGpPWpGaD
Varenicline—CHRNA7—forebrain—alcohol dependence	0.000746	0.0186	CbGeAlD
Varenicline—CHRNA4—forebrain—alcohol dependence	0.000736	0.0184	CbGeAlD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRB1—alcohol dependence	0.000718	0.015	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ6—alcohol dependence	0.000715	0.015	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—alcohol dependence	0.000693	0.0145	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ6—alcohol dependence	0.000679	0.0142	CbGpPWpGaD
Varenicline—CHRNA3—endocrine gland—alcohol dependence	0.000662	0.0166	CbGeAlD
Varenicline—CHRNB2—testis—alcohol dependence	0.000651	0.0163	CbGeAlD
Varenicline—CHRNA6—Neuronal System—KCNJ6—alcohol dependence	0.00065	0.0136	CbGpPWpGaD
Varenicline—CHRNB2—nervous system—alcohol dependence	0.000639	0.016	CbGeAlD
Varenicline—CHRNA3—testis—alcohol dependence	0.000632	0.0158	CbGeAlD
Varenicline—CHRNA7—cardiovascular system—alcohol dependence	0.000631	0.0158	CbGeAlD
Varenicline—CHRNA4—cardiovascular system—alcohol dependence	0.000622	0.0155	CbGeAlD
Varenicline—CHRNA3—nervous system—alcohol dependence	0.00062	0.0155	CbGeAlD
Varenicline—CHRFAM7A—blood—alcohol dependence	0.000618	0.0154	CbGeAlD
Varenicline—CHRNB2—liver—alcohol dependence	0.000616	0.0154	CbGeAlD
Varenicline—CHRNB2—central nervous system—alcohol dependence	0.000616	0.0154	CbGeAlD
Varenicline—CHRNA6—Transmission across Chemical Synapses—GABRB1—alcohol dependence	0.000613	0.0128	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—alcohol dependence	0.000611	0.0128	CbGpPWpGaD
Varenicline—CHRNB2—cerebellum—alcohol dependence	0.000602	0.015	CbGeAlD
Varenicline—CHRNA3—central nervous system—alcohol dependence	0.000597	0.0149	CbGeAlD
Varenicline—CHRNA3—cerebellum—alcohol dependence	0.000583	0.0146	CbGeAlD
Varenicline—CHRNB2—Neuronal System—KCNJ6—alcohol dependence	0.000572	0.012	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ6—alcohol dependence	0.000553	0.0116	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—GABRB1—alcohol dependence	0.00054	0.0113	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—KCNJ6—alcohol dependence	0.000538	0.0112	CbGpPWpGaD
Varenicline—CHRFAM7A—endocrine gland—alcohol dependence	0.000536	0.0134	CbGeAlD
Varenicline—CHRNA7—digestive system—alcohol dependence	0.000524	0.0131	CbGeAlD
Varenicline—CHRNA6—Transmission across Chemical Synapses—GABRA2—alcohol dependence	0.000521	0.0109	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRB1—alcohol dependence	0.000517	0.0108	CbGpPWpGaD
Varenicline—CHRNA4—digestive system—alcohol dependence	0.000517	0.0129	CbGeAlD
Varenicline—CHRFAM7A—testis—alcohol dependence	0.000511	0.0128	CbGeAlD
Varenicline—CHRNA7—Transmission across Chemical Synapses—KCNJ6—alcohol dependence	0.00051	0.0107	CbGpPWpGaD
Varenicline—CHRFAM7A—nervous system—alcohol dependence	0.000501	0.0125	CbGeAlD
Varenicline—CHRNA7—blood—alcohol dependence	0.000499	0.0125	CbGeAlD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRB1—alcohol dependence	0.000491	0.0103	CbGpPWpGaD
Varenicline—CHRNB2—brain—alcohol dependence	0.000489	0.0122	CbGeAlD
Varenicline—CHRNA4—midbrain—alcohol dependence	0.000486	0.0121	CbGeAlD
Varenicline—CHRFAM7A—central nervous system—alcohol dependence	0.000483	0.0121	CbGeAlD
Varenicline—CHRNA3—brain—alcohol dependence	0.000474	0.0118	CbGeAlD
Varenicline—CHRNA6—Neuronal System—GABRB1—alcohol dependence	0.00047	0.00983	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.000469	0.00982	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—GABRA2—alcohol dependence	0.000459	0.0096	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—alcohol dependence	0.00044	0.0092	CbGpPWpGaD
Varenicline—CHRNA7—endocrine gland—alcohol dependence	0.000433	0.0108	CbGeAlD
Varenicline—CHRNA4—endocrine gland—alcohol dependence	0.000427	0.0107	CbGeAlD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—alcohol dependence	0.000417	0.00873	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—KCNJ6—alcohol dependence	0.000416	0.0087	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—GABRB1—alcohol dependence	0.000414	0.00865	CbGpPWpGaD
Varenicline—CHRNA7—testis—alcohol dependence	0.000413	0.0103	CbGeAlD
Varenicline—CHRNA3—Neuronal System—KCNJ6—alcohol dependence	0.000412	0.00862	CbGpPWpGaD
Varenicline—CHRNA7—nervous system—alcohol dependence	0.000405	0.0101	CbGeAlD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRB1—alcohol dependence	0.0004	0.00837	CbGpPWpGaD
Varenicline—CHRNA4—nervous system—alcohol dependence	0.0004	0.00998	CbGeAlD
Varenicline—CHRNA6—Neuronal System—GABRA2—alcohol dependence	0.000399	0.00836	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—alcohol dependence	0.000398	0.00833	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—KCNJ6—alcohol dependence	0.000391	0.00818	CbGpPWpGaD
Varenicline—CHRNA7—central nervous system—alcohol dependence	0.00039	0.00974	CbGeAlD
Varenicline—CHRNA3—Transmission across Chemical Synapses—GABRB1—alcohol dependence	0.000389	0.00813	CbGpPWpGaD
Varenicline—CHRNA4—central nervous system—alcohol dependence	0.000385	0.00961	CbGeAlD
Varenicline—CHRFAM7A—brain—alcohol dependence	0.000383	0.00958	CbGeAlD
Varenicline—CHRNA6—Transmission across Chemical Synapses—ALDH2—alcohol dependence	0.000379	0.00792	CbGpPWpGaD
Varenicline—CHRNA4—cerebellum—alcohol dependence	0.000376	0.00939	CbGeAlD
Varenicline—CHRNA7—Transmission across Chemical Synapses—GABRB1—alcohol dependence	0.000369	0.00772	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.000356	0.00744	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—GABRA2—alcohol dependence	0.000352	0.00736	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—alcohol dependence	0.000351	0.00734	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—alcohol dependence	0.00034	0.00712	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—ALDH2—alcohol dependence	0.000333	0.00698	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—GABRA2—alcohol dependence	0.000331	0.00691	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.000321	0.00671	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—KCNJ6—alcohol dependence	0.000319	0.00667	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—GABRA2—alcohol dependence	0.000314	0.00656	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—CRH—alcohol dependence	0.000312	0.00653	CbGpPWpGaD
Varenicline—CHRNA7—brain—alcohol dependence	0.00031	0.00773	CbGeAlD
Varenicline—CHRNA4—brain—alcohol dependence	0.000305	0.00763	CbGeAlD
Varenicline—CHRNA4—Transmission across Chemical Synapses—GABRB1—alcohol dependence	0.000301	0.00629	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—GRIN2B—alcohol dependence	0.000299	0.00626	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—GABRB1—alcohol dependence	0.000298	0.00623	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—SLC6A3—alcohol dependence	0.000295	0.00617	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—SLC6A4—alcohol dependence	0.00029	0.00607	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—ALDH2—alcohol dependence	0.00029	0.00607	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—GABRB1—alcohol dependence	0.000283	0.00591	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—DRD4—alcohol dependence	0.000273	0.00571	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000268	0.0056	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—GRIN2B—alcohol dependence	0.000264	0.00552	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000262	0.00548	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.000261	0.00547	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—SLC6A3—alcohol dependence	0.00026	0.00544	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—GABRA2—alcohol dependence	0.000256	0.00535	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—ALDH2—alcohol dependence	0.000256	0.00535	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—HTR7—alcohol dependence	0.000254	0.00532	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—DRD2—alcohol dependence	0.000254	0.00532	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—GABRA2—alcohol dependence	0.000253	0.0053	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—alcohol dependence	0.000253	0.00528	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—MAOA—alcohol dependence	0.000249	0.00521	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.000243	0.00508	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—GABRA2—alcohol dependence	0.00024	0.00503	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—ALDH2—alcohol dependence	0.00024	0.00502	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—alcohol dependence	0.00024	0.00501	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—GABRB1—alcohol dependence	0.00023	0.00482	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—GRIN2B—alcohol dependence	0.000229	0.0048	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—ALDH2—alcohol dependence	0.000228	0.00477	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—SLC6A3—alcohol dependence	0.000226	0.00473	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—MAOA—alcohol dependence	0.000219	0.00459	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000218	0.00456	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—AVP—alcohol dependence	0.000214	0.00448	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—GRIN2B—alcohol dependence	0.000202	0.00423	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—SLC6A3—alcohol dependence	0.000199	0.00416	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.000198	0.00414	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—GABRA2—alcohol dependence	0.000196	0.0041	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—alcohol dependence	0.000195	0.00409	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—MAOA—alcohol dependence	0.000191	0.00399	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—GRIN2B—alcohol dependence	0.00019	0.00397	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—SLC6A3—alcohol dependence	0.000187	0.00391	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—ALDH2—alcohol dependence	0.000186	0.00389	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—ALDH2—alcohol dependence	0.000184	0.00385	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000183	0.00383	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—GRIN2B—alcohol dependence	0.00018	0.00377	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000179	0.00375	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—SLC6A3—alcohol dependence	0.000178	0.00371	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—ALDH2—alcohol dependence	0.000175	0.00365	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—MAOA—alcohol dependence	0.000168	0.00352	CbGpPWpGaD
Varenicline—Thirst—Citalopram—alcohol dependence	0.000161	0.00123	CcSEcCtD
Varenicline—Rash—Disulfiram—alcohol dependence	0.000161	0.00123	CcSEcCtD
Varenicline—Headache—Disulfiram—alcohol dependence	0.00016	0.00122	CcSEcCtD
Varenicline—Immune system disorder—Acamprosate—alcohol dependence	0.00016	0.00122	CcSEcCtD
Varenicline—Chills—Acamprosate—alcohol dependence	0.000159	0.00122	CcSEcCtD
Varenicline—CHRNA3—Transmission across Chemical Synapses—MAOA—alcohol dependence	0.000158	0.0033	CbGpPWpGaD
Varenicline—Arthritis—Citalopram—alcohol dependence	0.000158	0.00121	CcSEcCtD
Varenicline—Hypoglycaemia—Citalopram—alcohol dependence	0.000157	0.0012	CcSEcCtD
Varenicline—Cerebrovascular accident—Citalopram—alcohol dependence	0.000156	0.0012	CcSEcCtD
Varenicline—Lethargy—Citalopram—alcohol dependence	0.000156	0.0012	CcSEcCtD
Varenicline—Eye disorder—Naltrexone—alcohol dependence	0.000156	0.0012	CcSEcCtD
Varenicline—Tinnitus—Naltrexone—alcohol dependence	0.000156	0.00119	CcSEcCtD
Varenicline—Cardiac disorder—Naltrexone—alcohol dependence	0.000155	0.00119	CcSEcCtD
Varenicline—Mental disorder—Acamprosate—alcohol dependence	0.000155	0.00119	CcSEcCtD
Varenicline—Malnutrition—Acamprosate—alcohol dependence	0.000154	0.00118	CcSEcCtD
Varenicline—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.000153	0.00117	CcSEcCtD
Varenicline—Osteoarthritis—Citalopram—alcohol dependence	0.000153	0.00117	CcSEcCtD
Varenicline—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.000152	0.00116	CcSEcCtD
Varenicline—Angiopathy—Naltrexone—alcohol dependence	0.000152	0.00116	CcSEcCtD
Varenicline—Flatulence—Acamprosate—alcohol dependence	0.000152	0.00116	CcSEcCtD
Varenicline—Immune system disorder—Naltrexone—alcohol dependence	0.000151	0.00116	CcSEcCtD
Varenicline—Migraine—Citalopram—alcohol dependence	0.000151	0.00116	CcSEcCtD
Varenicline—Affect lability—Citalopram—alcohol dependence	0.000151	0.00116	CcSEcCtD
Varenicline—Mediastinal disorder—Naltrexone—alcohol dependence	0.000151	0.00115	CcSEcCtD
Varenicline—Dysgeusia—Acamprosate—alcohol dependence	0.000151	0.00115	CcSEcCtD
Varenicline—Chills—Naltrexone—alcohol dependence	0.00015	0.00115	CcSEcCtD
Varenicline—CHRNA7—Transmission across Chemical Synapses—MAOA—alcohol dependence	0.00015	0.00314	CbGpPWpGaD
Varenicline—Psychotic disorder—Citalopram—alcohol dependence	0.00015	0.00115	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000149	0.00312	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000149	0.00312	CbGpPWpGaD
Varenicline—Back pain—Acamprosate—alcohol dependence	0.000149	0.00114	CcSEcCtD
Varenicline—Muscle spasms—Acamprosate—alcohol dependence	0.000148	0.00113	CcSEcCtD
Varenicline—CHRNA4—Transmission across Chemical Synapses—GRIN2B—alcohol dependence	0.000147	0.00307	CbGpPWpGaD
Varenicline—Mental disorder—Naltrexone—alcohol dependence	0.000147	0.00112	CcSEcCtD
Varenicline—Irritability—Citalopram—alcohol dependence	0.000146	0.00112	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000146	0.00306	CbGpPWpGaD
Varenicline—Urinary retention—Citalopram—alcohol dependence	0.000146	0.00112	CcSEcCtD
Varenicline—Malnutrition—Naltrexone—alcohol dependence	0.000146	0.00112	CcSEcCtD
Varenicline—CHRNA3—Neuronal System—GRIN2B—alcohol dependence	0.000145	0.00304	CbGpPWpGaD
Varenicline—Mood swings—Citalopram—alcohol dependence	0.000145	0.00111	CcSEcCtD
Varenicline—CHRNA4—Transmission across Chemical Synapses—SLC6A3—alcohol dependence	0.000145	0.00303	CbGpPWpGaD
Varenicline—Tremor—Acamprosate—alcohol dependence	0.000144	0.0011	CcSEcCtD
Varenicline—Flatulence—Naltrexone—alcohol dependence	0.000143	0.0011	CcSEcCtD
Varenicline—CHRNA3—Neuronal System—SLC6A3—alcohol dependence	0.000143	0.003	CbGpPWpGaD
Varenicline—Ill-defined disorder—Acamprosate—alcohol dependence	0.000143	0.00109	CcSEcCtD
Varenicline—Dysgeusia—Naltrexone—alcohol dependence	0.000143	0.00109	CcSEcCtD
Varenicline—CHRNA4—Neuronal System—ALDH2—alcohol dependence	0.000142	0.00298	CbGpPWpGaD
Varenicline—Anaemia—Acamprosate—alcohol dependence	0.000142	0.00109	CcSEcCtD
Varenicline—Liver function test abnormal—Citalopram—alcohol dependence	0.000141	0.00108	CcSEcCtD
Varenicline—Agitation—Acamprosate—alcohol dependence	0.000141	0.00108	CcSEcCtD
Varenicline—Back pain—Naltrexone—alcohol dependence	0.000141	0.00108	CcSEcCtD
Varenicline—Angioedema—Acamprosate—alcohol dependence	0.000141	0.00108	CcSEcCtD
Varenicline—Dry skin—Citalopram—alcohol dependence	0.00014	0.00108	CcSEcCtD
Varenicline—Muscle spasms—Naltrexone—alcohol dependence	0.00014	0.00107	CcSEcCtD
Varenicline—Abdominal pain upper—Citalopram—alcohol dependence	0.00014	0.00107	CcSEcCtD
Varenicline—Hypokalaemia—Citalopram—alcohol dependence	0.000139	0.00107	CcSEcCtD
Varenicline—Malaise—Acamprosate—alcohol dependence	0.000139	0.00106	CcSEcCtD
Varenicline—Breast disorder—Citalopram—alcohol dependence	0.000138	0.00106	CcSEcCtD
Varenicline—Vertigo—Acamprosate—alcohol dependence	0.000138	0.00106	CcSEcCtD
Varenicline—Syncope—Acamprosate—alcohol dependence	0.000138	0.00106	CcSEcCtD
Varenicline—CHRNA7—Neuronal System—GRIN2B—alcohol dependence	0.000138	0.00289	CbGpPWpGaD
Varenicline—Cramp muscle—Citalopram—alcohol dependence	0.000138	0.00106	CcSEcCtD
Varenicline—Vision blurred—Naltrexone—alcohol dependence	0.000137	0.00105	CcSEcCtD
Varenicline—Nasopharyngitis—Citalopram—alcohol dependence	0.000137	0.00105	CcSEcCtD
Varenicline—Tremor—Naltrexone—alcohol dependence	0.000136	0.00105	CcSEcCtD
Varenicline—CHRNA7—Neuronal System—SLC6A3—alcohol dependence	0.000136	0.00285	CbGpPWpGaD
Varenicline—Palpitations—Acamprosate—alcohol dependence	0.000136	0.00104	CcSEcCtD
Varenicline—Gastritis—Citalopram—alcohol dependence	0.000136	0.00104	CcSEcCtD
Varenicline—Loss of consciousness—Acamprosate—alcohol dependence	0.000135	0.00104	CcSEcCtD
Varenicline—Ill-defined disorder—Naltrexone—alcohol dependence	0.000135	0.00103	CcSEcCtD
Varenicline—Cough—Acamprosate—alcohol dependence	0.000134	0.00103	CcSEcCtD
Varenicline—Agitation—Naltrexone—alcohol dependence	0.000134	0.00103	CcSEcCtD
Varenicline—Convulsion—Acamprosate—alcohol dependence	0.000133	0.00102	CcSEcCtD
Varenicline—Abdominal distension—Citalopram—alcohol dependence	0.000133	0.00102	CcSEcCtD
Varenicline—Angioedema—Naltrexone—alcohol dependence	0.000133	0.00102	CcSEcCtD
Varenicline—Hypertension—Acamprosate—alcohol dependence	0.000133	0.00102	CcSEcCtD
Varenicline—Dysphagia—Citalopram—alcohol dependence	0.000132	0.00101	CcSEcCtD
Varenicline—Asthma—Citalopram—alcohol dependence	0.000132	0.00101	CcSEcCtD
Varenicline—Malaise—Naltrexone—alcohol dependence	0.000131	0.00101	CcSEcCtD
Varenicline—Myalgia—Acamprosate—alcohol dependence	0.000131	0.001	CcSEcCtD
Varenicline—Arthralgia—Acamprosate—alcohol dependence	0.000131	0.001	CcSEcCtD
Varenicline—Chest pain—Acamprosate—alcohol dependence	0.000131	0.001	CcSEcCtD
Varenicline—Syncope—Naltrexone—alcohol dependence	0.000131	0.001	CcSEcCtD
Varenicline—Anxiety—Acamprosate—alcohol dependence	0.000131	0.001	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00013	0.000997	CcSEcCtD
Varenicline—Discomfort—Acamprosate—alcohol dependence	0.000129	0.000992	CcSEcCtD
Varenicline—Angina pectoris—Citalopram—alcohol dependence	0.000129	0.000988	CcSEcCtD
Varenicline—Palpitations—Naltrexone—alcohol dependence	0.000129	0.000986	CcSEcCtD
Varenicline—Dry mouth—Acamprosate—alcohol dependence	0.000128	0.000982	CcSEcCtD
Varenicline—Loss of consciousness—Naltrexone—alcohol dependence	0.000128	0.00098	CcSEcCtD
Varenicline—Bronchitis—Citalopram—alcohol dependence	0.000127	0.000976	CcSEcCtD
Varenicline—Cough—Naltrexone—alcohol dependence	0.000127	0.000973	CcSEcCtD
Varenicline—Abdominal discomfort—Citalopram—alcohol dependence	0.000127	0.000972	CcSEcCtD
Varenicline—Convulsion—Naltrexone—alcohol dependence	0.000126	0.000966	CcSEcCtD
Varenicline—Hypertension—Naltrexone—alcohol dependence	0.000126	0.000963	CcSEcCtD
Varenicline—Infection—Acamprosate—alcohol dependence	0.000125	0.000956	CcSEcCtD
Varenicline—Myalgia—Naltrexone—alcohol dependence	0.000124	0.00095	CcSEcCtD
Varenicline—Chest pain—Naltrexone—alcohol dependence	0.000124	0.00095	CcSEcCtD
Varenicline—Arthralgia—Naltrexone—alcohol dependence	0.000124	0.00095	CcSEcCtD
Varenicline—Shock—Acamprosate—alcohol dependence	0.000124	0.000947	CcSEcCtD
Varenicline—Anxiety—Naltrexone—alcohol dependence	0.000124	0.000946	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000123	0.000943	CcSEcCtD
Varenicline—Thrombocytopenia—Acamprosate—alcohol dependence	0.000123	0.000942	CcSEcCtD
Varenicline—Tachycardia—Acamprosate—alcohol dependence	0.000123	0.000939	CcSEcCtD
Varenicline—Discomfort—Naltrexone—alcohol dependence	0.000122	0.000938	CcSEcCtD
Varenicline—Pollakiuria—Citalopram—alcohol dependence	0.000122	0.000937	CcSEcCtD
Varenicline—CHRNA4—Transmission across Chemical Synapses—MAOA—alcohol dependence	0.000122	0.00256	CbGpPWpGaD
Varenicline—Skin disorder—Acamprosate—alcohol dependence	0.000122	0.000935	CcSEcCtD
Varenicline—Erectile dysfunction—Citalopram—alcohol dependence	0.000122	0.000934	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000122	0.00254	CbGpPWpGaD
Varenicline—Hyperhidrosis—Acamprosate—alcohol dependence	0.000121	0.00093	CcSEcCtD
Varenicline—Dry mouth—Naltrexone—alcohol dependence	0.000121	0.000929	CcSEcCtD
Varenicline—CHRNA3—Neuronal System—MAOA—alcohol dependence	0.000121	0.00253	CbGpPWpGaD
Varenicline—Photosensitivity reaction—Citalopram—alcohol dependence	0.000121	0.000926	CcSEcCtD
Varenicline—Weight increased—Citalopram—alcohol dependence	0.000121	0.000923	CcSEcCtD
Varenicline—Anorexia—Acamprosate—alcohol dependence	0.00012	0.000917	CcSEcCtD
Varenicline—Hyperglycaemia—Citalopram—alcohol dependence	0.000119	0.000915	CcSEcCtD
Varenicline—Oedema—Naltrexone—alcohol dependence	0.000119	0.00091	CcSEcCtD
Varenicline—Infection—Naltrexone—alcohol dependence	0.000118	0.000904	CcSEcCtD
Varenicline—Infestation—Citalopram—alcohol dependence	0.000118	0.000904	CcSEcCtD
Varenicline—Infestation NOS—Citalopram—alcohol dependence	0.000118	0.000904	CcSEcCtD
Varenicline—Depression—Citalopram—alcohol dependence	0.000118	0.000902	CcSEcCtD
Varenicline—Hypotension—Acamprosate—alcohol dependence	0.000117	0.000899	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000117	0.000897	CcSEcCtD
Varenicline—Shock—Naltrexone—alcohol dependence	0.000117	0.000896	CcSEcCtD
Varenicline—Nervous system disorder—Naltrexone—alcohol dependence	0.000117	0.000893	CcSEcCtD
Varenicline—Acute coronary syndrome—Citalopram—alcohol dependence	0.000116	0.000892	CcSEcCtD
Varenicline—Tachycardia—Naltrexone—alcohol dependence	0.000116	0.000889	CcSEcCtD
Varenicline—Myocardial infarction—Citalopram—alcohol dependence	0.000116	0.000887	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—EP300—alcohol dependence	0.000116	0.00242	CbGpPWpGaD
Varenicline—Skin disorder—Naltrexone—alcohol dependence	0.000115	0.000884	CcSEcCtD
Varenicline—Stomatitis—Citalopram—alcohol dependence	0.000115	0.000882	CcSEcCtD
Varenicline—Hyperhidrosis—Naltrexone—alcohol dependence	0.000115	0.00088	CcSEcCtD
Varenicline—CHRNA7—Neuronal System—MAOA—alcohol dependence	0.000115	0.0024	CbGpPWpGaD
Varenicline—Conjunctivitis—Citalopram—alcohol dependence	0.000115	0.000879	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000114	0.000877	CcSEcCtD
Varenicline—Insomnia—Acamprosate—alcohol dependence	0.000114	0.00087	CcSEcCtD
Varenicline—Anorexia—Naltrexone—alcohol dependence	0.000113	0.000868	CcSEcCtD
Varenicline—CHRNA4—Neuronal System—GRIN2B—alcohol dependence	0.000113	0.00235	CbGpPWpGaD
Varenicline—Dyspnoea—Acamprosate—alcohol dependence	0.000112	0.000858	CcSEcCtD
Varenicline—Somnolence—Acamprosate—alcohol dependence	0.000112	0.000855	CcSEcCtD
Varenicline—Hepatobiliary disease—Citalopram—alcohol dependence	0.000112	0.000855	CcSEcCtD
Varenicline—Epistaxis—Citalopram—alcohol dependence	0.000111	0.000853	CcSEcCtD
Varenicline—CHRNA4—Neuronal System—SLC6A3—alcohol dependence	0.000111	0.00232	CbGpPWpGaD
Varenicline—Sinusitis—Citalopram—alcohol dependence	0.000111	0.000849	CcSEcCtD
Varenicline—Dyspepsia—Acamprosate—alcohol dependence	0.000111	0.000847	CcSEcCtD
Varenicline—Decreased appetite—Acamprosate—alcohol dependence	0.000109	0.000836	CcSEcCtD
Varenicline—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000108	0.000831	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000108	0.000829	CcSEcCtD
Varenicline—Bradycardia—Citalopram—alcohol dependence	0.000108	0.000827	CcSEcCtD
Varenicline—Insomnia—Naltrexone—alcohol dependence	0.000107	0.000823	CcSEcCtD
Varenicline—Pain—Acamprosate—alcohol dependence	0.000107	0.000823	CcSEcCtD
Varenicline—Constipation—Acamprosate—alcohol dependence	0.000107	0.000823	CcSEcCtD
Varenicline—Dyspnoea—Naltrexone—alcohol dependence	0.000106	0.000812	CcSEcCtD
Varenicline—Somnolence—Naltrexone—alcohol dependence	0.000106	0.000809	CcSEcCtD
Varenicline—Hypoaesthesia—Citalopram—alcohol dependence	0.000105	0.000808	CcSEcCtD
Varenicline—Hallucination—Citalopram—alcohol dependence	0.000105	0.000808	CcSEcCtD
Varenicline—Urinary tract disorder—Citalopram—alcohol dependence	0.000105	0.000802	CcSEcCtD
Varenicline—Oedema peripheral—Citalopram—alcohol dependence	0.000104	0.0008	CcSEcCtD
Varenicline—Connective tissue disorder—Citalopram—alcohol dependence	0.000104	0.000798	CcSEcCtD
Varenicline—Urethral disorder—Citalopram—alcohol dependence	0.000104	0.000796	CcSEcCtD
Varenicline—Feeling abnormal—Acamprosate—alcohol dependence	0.000104	0.000793	CcSEcCtD
Varenicline—Decreased appetite—Naltrexone—alcohol dependence	0.000103	0.000791	CcSEcCtD
Varenicline—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000103	0.000787	CcSEcCtD
Varenicline—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000103	0.000786	CcSEcCtD
Varenicline—Fatigue—Naltrexone—alcohol dependence	0.000102	0.000785	CcSEcCtD
Varenicline—Visual impairment—Citalopram—alcohol dependence	0.000102	0.000782	CcSEcCtD
Varenicline—Pain—Naltrexone—alcohol dependence	0.000102	0.000779	CcSEcCtD
Varenicline—Constipation—Naltrexone—alcohol dependence	0.000102	0.000779	CcSEcCtD
Varenicline—Erythema multiforme—Citalopram—alcohol dependence	0.0001	0.000768	CcSEcCtD
Varenicline—Urticaria—Acamprosate—alcohol dependence	9.98e-05	0.000764	CcSEcCtD
Varenicline—Abdominal pain—Acamprosate—alcohol dependence	9.93e-05	0.000761	CcSEcCtD
Varenicline—Body temperature increased—Acamprosate—alcohol dependence	9.93e-05	0.000761	CcSEcCtD
Varenicline—Eye disorder—Citalopram—alcohol dependence	9.91e-05	0.000759	CcSEcCtD
Varenicline—Tinnitus—Citalopram—alcohol dependence	9.88e-05	0.000757	CcSEcCtD
Varenicline—Cardiac disorder—Citalopram—alcohol dependence	9.84e-05	0.000754	CcSEcCtD
Varenicline—Feeling abnormal—Naltrexone—alcohol dependence	9.79e-05	0.00075	CcSEcCtD
Varenicline—Gastrointestinal pain—Naltrexone—alcohol dependence	9.72e-05	0.000744	CcSEcCtD
Varenicline—Angiopathy—Citalopram—alcohol dependence	9.62e-05	0.000737	CcSEcCtD
Varenicline—Immune system disorder—Citalopram—alcohol dependence	9.57e-05	0.000733	CcSEcCtD
Varenicline—Mediastinal disorder—Citalopram—alcohol dependence	9.55e-05	0.000732	CcSEcCtD
Varenicline—Chills—Citalopram—alcohol dependence	9.51e-05	0.000729	CcSEcCtD
Varenicline—Arrhythmia—Citalopram—alcohol dependence	9.47e-05	0.000725	CcSEcCtD
Varenicline—Urticaria—Naltrexone—alcohol dependence	9.44e-05	0.000723	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—EP300—alcohol dependence	9.44e-05	0.00197	CbGpPWpGaD
Varenicline—Abdominal pain—Naltrexone—alcohol dependence	9.4e-05	0.00072	CcSEcCtD
Varenicline—Body temperature increased—Naltrexone—alcohol dependence	9.4e-05	0.00072	CcSEcCtD
Varenicline—CHRNA4—Neuronal System—MAOA—alcohol dependence	9.36e-05	0.00196	CbGpPWpGaD
Varenicline—Mental disorder—Citalopram—alcohol dependence	9.29e-05	0.000711	CcSEcCtD
Varenicline—Hypersensitivity—Acamprosate—alcohol dependence	9.25e-05	0.000709	CcSEcCtD
Varenicline—Erythema—Citalopram—alcohol dependence	9.23e-05	0.000707	CcSEcCtD
Varenicline—Malnutrition—Citalopram—alcohol dependence	9.23e-05	0.000707	CcSEcCtD
Varenicline—Flatulence—Citalopram—alcohol dependence	9.09e-05	0.000696	CcSEcCtD
Varenicline—Dysgeusia—Citalopram—alcohol dependence	9.04e-05	0.000692	CcSEcCtD
Varenicline—Asthenia—Acamprosate—alcohol dependence	9.01e-05	0.00069	CcSEcCtD
Varenicline—Back pain—Citalopram—alcohol dependence	8.93e-05	0.000684	CcSEcCtD
Varenicline—Pruritus—Acamprosate—alcohol dependence	8.89e-05	0.000681	CcSEcCtD
Varenicline—Muscle spasms—Citalopram—alcohol dependence	8.87e-05	0.00068	CcSEcCtD
Varenicline—Hypersensitivity—Naltrexone—alcohol dependence	8.76e-05	0.000671	CcSEcCtD
Varenicline—Vision blurred—Citalopram—alcohol dependence	8.7e-05	0.000666	CcSEcCtD
Varenicline—Tremor—Citalopram—alcohol dependence	8.64e-05	0.000662	CcSEcCtD
Varenicline—Diarrhoea—Acamprosate—alcohol dependence	8.59e-05	0.000658	CcSEcCtD
Varenicline—Ill-defined disorder—Citalopram—alcohol dependence	8.56e-05	0.000656	CcSEcCtD
Varenicline—Anaemia—Citalopram—alcohol dependence	8.53e-05	0.000653	CcSEcCtD
Varenicline—Asthenia—Naltrexone—alcohol dependence	8.53e-05	0.000653	CcSEcCtD
Varenicline—Agitation—Citalopram—alcohol dependence	8.48e-05	0.00065	CcSEcCtD
Varenicline—Angioedema—Citalopram—alcohol dependence	8.43e-05	0.000646	CcSEcCtD
Varenicline—Pruritus—Naltrexone—alcohol dependence	8.41e-05	0.000644	CcSEcCtD
Varenicline—Malaise—Citalopram—alcohol dependence	8.32e-05	0.000637	CcSEcCtD
Varenicline—Dizziness—Acamprosate—alcohol dependence	8.31e-05	0.000636	CcSEcCtD
Varenicline—Vertigo—Citalopram—alcohol dependence	8.29e-05	0.000635	CcSEcCtD
Varenicline—Syncope—Citalopram—alcohol dependence	8.27e-05	0.000634	CcSEcCtD
Varenicline—Palpitations—Citalopram—alcohol dependence	8.15e-05	0.000625	CcSEcCtD
Varenicline—Diarrhoea—Naltrexone—alcohol dependence	8.13e-05	0.000623	CcSEcCtD
Varenicline—Loss of consciousness—Citalopram—alcohol dependence	8.11e-05	0.000621	CcSEcCtD
Varenicline—Cough—Citalopram—alcohol dependence	8.05e-05	0.000617	CcSEcCtD
Varenicline—Convulsion—Citalopram—alcohol dependence	7.99e-05	0.000612	CcSEcCtD
Varenicline—Vomiting—Acamprosate—alcohol dependence	7.99e-05	0.000612	CcSEcCtD
Varenicline—Hypertension—Citalopram—alcohol dependence	7.97e-05	0.00061	CcSEcCtD
Varenicline—Rash—Acamprosate—alcohol dependence	7.92e-05	0.000607	CcSEcCtD
Varenicline—Dermatitis—Acamprosate—alcohol dependence	7.91e-05	0.000606	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—EP300—alcohol dependence	7.9e-05	0.00165	CbGpPWpGaD
Varenicline—Headache—Acamprosate—alcohol dependence	7.87e-05	0.000603	CcSEcCtD
Varenicline—Dizziness—Naltrexone—alcohol dependence	7.86e-05	0.000602	CcSEcCtD
Varenicline—Arthralgia—Citalopram—alcohol dependence	7.86e-05	0.000602	CcSEcCtD
Varenicline—Chest pain—Citalopram—alcohol dependence	7.86e-05	0.000602	CcSEcCtD
Varenicline—Myalgia—Citalopram—alcohol dependence	7.86e-05	0.000602	CcSEcCtD
Varenicline—Anxiety—Citalopram—alcohol dependence	7.83e-05	0.0006	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	7.8e-05	0.000598	CcSEcCtD
Varenicline—Discomfort—Citalopram—alcohol dependence	7.76e-05	0.000595	CcSEcCtD
Varenicline—Dry mouth—Citalopram—alcohol dependence	7.68e-05	0.000588	CcSEcCtD
Varenicline—Vomiting—Naltrexone—alcohol dependence	7.56e-05	0.000579	CcSEcCtD
Varenicline—Oedema—Citalopram—alcohol dependence	7.53e-05	0.000577	CcSEcCtD
Varenicline—Rash—Naltrexone—alcohol dependence	7.49e-05	0.000574	CcSEcCtD
Varenicline—Dermatitis—Naltrexone—alcohol dependence	7.49e-05	0.000573	CcSEcCtD
Varenicline—Infection—Citalopram—alcohol dependence	7.48e-05	0.000573	CcSEcCtD
Varenicline—Nausea—Acamprosate—alcohol dependence	7.46e-05	0.000572	CcSEcCtD
Varenicline—Headache—Naltrexone—alcohol dependence	7.45e-05	0.00057	CcSEcCtD
Varenicline—Shock—Citalopram—alcohol dependence	7.41e-05	0.000568	CcSEcCtD
Varenicline—Nervous system disorder—Citalopram—alcohol dependence	7.38e-05	0.000566	CcSEcCtD
Varenicline—Thrombocytopenia—Citalopram—alcohol dependence	7.37e-05	0.000565	CcSEcCtD
Varenicline—Tachycardia—Citalopram—alcohol dependence	7.35e-05	0.000563	CcSEcCtD
Varenicline—Skin disorder—Citalopram—alcohol dependence	7.31e-05	0.00056	CcSEcCtD
Varenicline—Hyperhidrosis—Citalopram—alcohol dependence	7.28e-05	0.000558	CcSEcCtD
Varenicline—Anorexia—Citalopram—alcohol dependence	7.18e-05	0.00055	CcSEcCtD
Varenicline—Nausea—Naltrexone—alcohol dependence	7.06e-05	0.000541	CcSEcCtD
Varenicline—Hypotension—Citalopram—alcohol dependence	7.04e-05	0.000539	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Citalopram—alcohol dependence	6.86e-05	0.000526	CcSEcCtD
Varenicline—Insomnia—Citalopram—alcohol dependence	6.81e-05	0.000522	CcSEcCtD
Varenicline—Dyspnoea—Citalopram—alcohol dependence	6.71e-05	0.000514	CcSEcCtD
Varenicline—Somnolence—Citalopram—alcohol dependence	6.69e-05	0.000513	CcSEcCtD
Varenicline—Dyspepsia—Citalopram—alcohol dependence	6.63e-05	0.000508	CcSEcCtD
Varenicline—Decreased appetite—Citalopram—alcohol dependence	6.55e-05	0.000501	CcSEcCtD
Varenicline—Gastrointestinal disorder—Citalopram—alcohol dependence	6.5e-05	0.000498	CcSEcCtD
Varenicline—Fatigue—Citalopram—alcohol dependence	6.49e-05	0.000497	CcSEcCtD
Varenicline—Pain—Citalopram—alcohol dependence	6.44e-05	0.000493	CcSEcCtD
Varenicline—Constipation—Citalopram—alcohol dependence	6.44e-05	0.000493	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—EP300—alcohol dependence	6.44e-05	0.00135	CbGpPWpGaD
Varenicline—Feeling abnormal—Citalopram—alcohol dependence	6.21e-05	0.000475	CcSEcCtD
Varenicline—Gastrointestinal pain—Citalopram—alcohol dependence	6.16e-05	0.000472	CcSEcCtD
Varenicline—Urticaria—Citalopram—alcohol dependence	5.98e-05	0.000458	CcSEcCtD
Varenicline—Body temperature increased—Citalopram—alcohol dependence	5.95e-05	0.000456	CcSEcCtD
Varenicline—Abdominal pain—Citalopram—alcohol dependence	5.95e-05	0.000456	CcSEcCtD
Varenicline—Hypersensitivity—Citalopram—alcohol dependence	5.55e-05	0.000425	CcSEcCtD
Varenicline—Asthenia—Citalopram—alcohol dependence	5.4e-05	0.000414	CcSEcCtD
Varenicline—Pruritus—Citalopram—alcohol dependence	5.33e-05	0.000408	CcSEcCtD
Varenicline—Diarrhoea—Citalopram—alcohol dependence	5.15e-05	0.000395	CcSEcCtD
Varenicline—Dizziness—Citalopram—alcohol dependence	4.98e-05	0.000381	CcSEcCtD
Varenicline—Vomiting—Citalopram—alcohol dependence	4.79e-05	0.000367	CcSEcCtD
Varenicline—Rash—Citalopram—alcohol dependence	4.75e-05	0.000364	CcSEcCtD
Varenicline—Dermatitis—Citalopram—alcohol dependence	4.74e-05	0.000363	CcSEcCtD
Varenicline—Headache—Citalopram—alcohol dependence	4.72e-05	0.000361	CcSEcCtD
Varenicline—Nausea—Citalopram—alcohol dependence	4.47e-05	0.000343	CcSEcCtD
